SCHEMBL13623258

SCHEMBL13623258

c1ccc(N2c3ccccc3CCc3cc(-c4c5ccccc5c(-c5ccc6c(c5)CCc5ccccc5N6c5ccccc5)c5ccccc45)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
ADRA2A P08913 3/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
HSD17B3 P37058 2/20 0.38
GAA P10253 1/20 0.35
GFER P55789 1/20 0.35
ALDH1A1 P00352 3/20 0.34
SRD5A1 P18405 1/20 0.34
CYP11B1 P15538 3/20 0.34
CYP11B2 P19099 3/20 0.34
CYP17A1 P05093 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP19A1 P11511 1/20 0.32
POLB P06746 1/20 0.32
SLC6A2 P23975 2/20 0.32
KDM4C Q9H3R0 1/20 0.32
TSHR P16473 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13158706 0.91 HSD17B3 (0.41) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL13623260 0.88 HPGD (0.41) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL13623253 0.87 HSD17B3 (0.48) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL13623259 0.85 ALDH1A1 (0.41) HPGDHSD17B3GAAALDH1A1CYP11B1
SCHEMBL13326574 0.83 SRD5A1 (0.39) HPGDHSD17B3GAAALDH1A1SRD5A1
SCHEMBL10010192 0.82 PGR (0.34) HSD17B3CYP11B1CYP11B2
SCHEMBL1102961 0.81 ADRA2A (0.37) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL1102692 0.81 ADRA2A (0.37) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL13158700 0.80 HPGD (0.41) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL14281334 0.80 HPGD (0.59) HPGDADRA2AADRA2BADRA2CHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R HPGD 3468/4885ADRA2A 545/4885ADRA2B 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.